Answers are grounded in this paper and cite their sources.
Observes apolipoprotein E allele frequencies in Parkinson's disease, suggesting ε4 increases risk while ε3 provides protection.
Background: The association of the apolipoprotein (Apo E) -epsilon4 allele to neurodegenerative diseases such as Parkinson’s disease (PD) has been analyzed in several studies. This association has been identified by amyloid deposits and neurofibrillary tangles in the brains of patients with neurodegenerative diseases. Method: In this study the possible relationship betweenApo Ealleles and PD patients was analyzed in 105 patients with PD and 107 healthy controls from a Mexican population. Results: Allele analysis in PD vs. controls was: ε2in 6% and 2.3%, respectively; ε3in 73% and 88.3%; and ε4in 21% and 9.4%. The ε3allele showed a protective risk effect with an Odds ratio (OR) of 0.36 (95%CI 0.20-0.61) and p < 0.05; contrary results were observed for the ε4allele, which showed an increased risk for PD, with an OR of 2.57(95% CI 1.42-4.79) andp< 0.05. Upon multivariate analysis showed PD risk was evident in patients who were carriers of the genotype ε3/ε4; age group (fifty or more years) and had exposure to pesticides and solvents (p< 0.05). Conclusions: The ε3/ε3; ε3/ε4genotypes of the Apo E, were positively associated with sporadic PD.
No takes yet. Share an insight, caveat, or question.
Gallegos‐Arreola et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: